Table 2.
Participant’s knowledge of pharmacogenomics (PGx).
| Statement | True % (N = 131) | False % (N = 131) | Not Sure % (N = 131) |
|---|---|---|---|
| Subtle differences in a person’s genome can have a major impact on how the person responds to medications. | 127 (97%) * | 1 (1%) | 3 (2%) |
| Genetic determinants of drugs response change over a person’s lifetime. | 30 (23%) | 83 (63%) * | 18 (14%) |
| Genetic variants can account for 95% of the variability in drug disposition and effects. | 18 (14%) * | 59 (45%) | 54 (41%) |
| The package insert for warfarin includes a warning about altered metabolism in individuals who have specific genetic variants. | 34 (26%) | 34 (26%) * | 63 (48%) |
| PGx testing is currently available for most medications. | 8 (6%) | 86 (66%) * | 37 (28%) |
Answers to Knowledge Questions: 1. True 2. False 3. True 4. True 5. False; * Percentage of respondents who got the questions correct on each knowledge question.